Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients

Conditions:   Malnutrition, Child;   Malnutrition Intervention:   Drug: SMOFlipid® (lipid injectable emulsion) Sponsor:   Fresenius Kabi Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials